Molecular formula: | C10H17N3S |
Average mass: | 211.327 |
Monoisotopic mass: | 211.114319 |
ChemSpider ID: | 106770 |
1 of 1 defined stereocentres
Wikipedia
(+)-pramipexole
(6S)-N~6~-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2,6-diamin
[German]
[ACD/IUPAC Name](6S)-N~6~-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
[ACD/IUPAC Name](6S)-N~6~-Propyl-4,5,6,7-tétrahydro-1,3-benzothiazole-2,6-diamine
[French]
[ACD/IUPAC Name](S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole
(S)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine
(S)-Pramipexole
104632-26-0
[RN]2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N~6~-propyl-, (6S)-
[ACD/Index Name]83619PEU5T
[UNII][(6S)-2-Amino(4,5,6,7-tetrahydrobenzothiazol-6-yl)]propylamine
pramipexol
pramipexolum
[Latin]
T56 BN DSJ CZ GM3 &&S Form
[WLN]U 98528E
(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(6S)-N′-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(S)-2-AMINO-6-PROPYLAMINO-4,5,6,7-TETRAHYDROBENZTHIAZOLE
(S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
(−)-Pramipexole; (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; Pramipexol; Pramipexole; Pramipexolum
10463-26-0
[RN]1217695-77-6
[RN]1649-18-9
[RN]2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-
5-hydroxytryptamine receptor 1A
5-hydroxytryptamine receptor 1B
5-hydroxytryptamine receptor 1D
5-hydroxytryptamine receptor 1E
5-hydroxytryptamine receptor 3A
5-hydroxytryptamine receptor 5A
5-hydroxytryptamine receptor 6
5-hydroxytryptamine receptor 7
5HT1A_HUMAN
5HT1B_HUMAN
5HT1D_HUMAN
5HT1E_HUMAN
5HT3A_HUMAN
5HT5A_HUMAN
5HT6R_HUMAN
5HT7R_HUMAN
6479326
[Beilstein]99%
[(6S)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]-propyl-amine
ACM1_HUMAN
ACM2_HUMAN
ACM3_HUMAN
ADA1A_HUMAN
ADA2A_HUMAN
ADA2B_HUMAN
ADA2C_HUMAN
ADRB2_HUMAN
ADRB3_HUMAN
CFTR_HUMAN
D(1A) dopamine receptor
D(1B) dopamine receptor
D(2) dopamine receptor
D(3) dopamine receptor
D(4) dopamine receptor
DRD1_HUMAN
DRD2_HUMAN
DRD3_HUMAN
DRD4_HUMAN
DRD5_HUMAN
Glepark
[Trade name]Glepark; Medopexol; Miramel; Miraper; Mirapexin; Pexola; Sifrol; Sifrol ER
Histamine H1 receptor
Histamine H2 receptor
Histamine H4 receptor
HRH1_HUMAN
HRH2_HUMAN
HRH4_HUMAN
Medopexol
[Trade name]MFCD00866692
[MDL number]MFCD00869076
[MDL number]Miramel
[Trade name]Miraper
[Trade name]Mirapex;Mirapexin;Sifrol
Mirapexin
[Trade name]Mirapexin, Sifrol
Mirapexin®
Mirapex®
Muscarinic acetylcholine receptor M1
Muscarinic acetylcholine receptor M2
Muscarinic acetylcholine receptor M3
N*6*-Propyl-4,5,6,7-tetrahydro-benzothiazole-2,6-diamine
OPRD_HUMAN
Pexola
[Trade name]pramipexol; pramipexole; pramipexolum
Pramipexole (Mirapex)
pramipexolum
SGMR1_HUMAN
Sifrol
[Trade name]Sifrol ER
Sifrol®
SND-919CL2Y
Spectrum5_001453
SUD919CL2Y
U-98528E
α-1A adrenergic receptor
α-2A adrenergic receptor
α-2B adrenergic receptor
α-2C adrenergic receptor
β-2 adrenergic receptor
β-3 adrenergic receptor
Δ-type opioid receptor